Drug · DIN 02492199
AMLODIPINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 11, 2026; first marketed August 24, 2020.
- Drug Identification Number (DIN)
- 02492199
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Amlodipine C08CA01
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMLODIPINE (AMLODIPINE BESYLATE) | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 18, 2023: NOC 31648Supplement to an Abbreviated New Drug Submission (SANDS) · New strength. Update to the Product Monograph and Package Insert. Update to Labels
- September 11, 2019: NOC 22642Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named AMLODIPINE
- DIN 02326795 · Marketed
- DIN 02326809 · Marketed
- DIN 02326817 · Marketed
- DIN 02331284 · Marketed
- DIN 02331292 · Marketed
- DIN 02385783 · Marketed
- DIN 02385791 · Marketed
- DIN 02385805 · Marketed
- DIN 02429217 · Marketed
- DIN 02429225 · Marketed
- DIN 02478587 · Marketed
- DIN 02490781 · Marketed
- DIN 02490803 · Marketed
- DIN 02490811 · Marketed
- DIN 02552868 · Marketed
- DIN 02552876 · Marketed
- DIN 02552884 · Marketed
- DIN 02343193 · Cancelled Post Market
- DIN 02343207 · Cancelled Post Market
- DIN 02343215 · Cancelled Post Market